CompoAtlas

ADRIEN GAGNON RHUME ET GRIPPE JOUR/COLD AND FLU DAY

ADRIEN GAGNON RHUME ET GRIPPE JOUR/COLD AND FLU DAY, NPN 80094113: natural health product licensed in Canada. Medicinal ingredients: Zingiber officinale, Serratiopeptidase, Sambucus nigra subsp. nigra.

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zingiber officinale

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,500 mg

150 mgNot calculated
Serratiopeptidase

Source : Serratia marcescens E-15 - Cellule Entiière

100 mgNot calculated
Sambucus nigra subsp. nigra

Source : Fruits comestibles parties

Extract : Matériel brut sec

Extraction ratio : 64:1

Dry plant equivalent : 3,200 mg

50 mgNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

ELDER - SAMBUCUS (Traditionally) used in Herbal Medicine to promote sweating (diaphoretic) to help relieve fever (in cases of common colds, flus). (Traditionally) used in Herbal Medicine to help relieve symptoms of colds and flus (such as coughs, sore throat and mucus buildup (catarrh) of the (upper) respiratory tract). (Traditionally) used in Herbal Medicine to help relieve joint pain associated with conditions such as arthritis. (Traditionally) used in Herbal Medicine (as an alterative) to help remove accumulated waste products via the kidneys, skin and mucus membranes. Source of/Provides antioxidants. (Traditionally) used in Herbal Medicine to promote sweating (diaphoretic) to help relieve fever (in cases of the common cold, flus) and to help relieve symptoms of colds and flus (such as coughs, sore throat and mucus buildup (catarrh) of the (upper) respiratory tract). WILLOW BARK Used in Herbal Medicine for short-term relief of low back pain. (Traditionally) used in Herbal Medicine to relieve minor joint pain (due to osteoarthritis). (Traditionally) used in Herbal Medicine to relieve fever associated with the common cold. (Traditionally) used in Herbal Medicine to relieve headache pain. (Traditionally) used in Herbal Medicine to relieve minor joint pain (due to osteoarthritis), headache pain and for short-term relief of low back pain. GINGER - ZINGIBER OFFICINALE Traditionally used in Herbal Medicine to help relieve digestive upset including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia, and flatulent colic (carminative). Traditionally used in Herbal Medicine as an expectorant and cough suppressant (antitussive) to help relieve bronchitis as well as coughs and colds.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Santé Naturelle (A.G.) Ltée
NPN or DIN-HM
80094113
Status
Active licence
Licence date
25 August 2019
Revision date
11 April 2023
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80094113

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Serratiopeptidase
    Read the warning, when it applies and the studies cited

    SERRAPEPTASE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).

    Sources cited by Health Canada (4)
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
    • Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
    • Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
    • Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).

    Sources cited by Health Canada (4)
    • Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
    • Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
    • Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial

    Known adverse reactions

    Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).

    Sources cited by Health Canada (1)
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • Sambucus nigra subsp. nigra
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “ADRIEN GAGNON RHUME ET GRIPPE JOUR/COLD AND FLU DAY (Santé Naturelle (A.G.) Ltée): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80094113-adrien-gagnon-rhume-et-grippe-jour-cold-and-flu-day, updated 11 April 2023.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line